Johnson & Johnson’s recent FDA approval for a drug-eluting contact lens has changed the game for contact lens wearers suffering from allergic eye itch. Now, medtech analysts at Needham & Co. have issued a report that takes a closer look at both the contact lens market and the intraocular lens market, noting how both markets are poised for growth. The analysts see a mix shift toward premium lenses as a durable growth driver for the roughly $9B contact lens market. They also expect premium lenses in cataract surgeries to drive growth in the intraocular lens (IOL) market. The analysts estimate the IOL market is currently valued at about $3B.

Categorized in: